Lacritin and other new proteins of the lacrimal functional unit

Experimental Eye Research

Volumn 88, Issue 5, 2009, Pages 848-858

  McKown, Robert L ^a   Wang, Ningning ^b   Raab, Ronald W ^a   Karnati, Roy ^b   Zhang, Yinghui ^b   Williams, Patricia B ^c   Laurie, Gordon W ^b  

^a JAMES MADISON UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

cornea; dry eye; lacrimal; LACRT; LFU; meibomian

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PROTEIN LACRITIN; SYNDECAN 1; TEAR PROTEIN; UNCLASSIFIED DRUG;

BINDING SITE; CELL SURFACE; CORNEA EPITHELIUM; HUMAN; LACRIMAL GLAND FUNCTION; LACRIMATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; RISK FACTOR;

ANIMALS; AUTOIMMUNE DISEASES; CORNEA; DRY EYE SYNDROMES; EYE PROTEINS; GENE EXPRESSION REGULATION; GENETIC DISEASES, INBORN; GENETIC PREDISPOSITION TO DISEASE; GLYCOPROTEINS; HUMANS; LACRIMAL APPARATUS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 64849105312     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.09.002     Document Type: Review

References (75)

1. Lemp M.A., Baudouin C., Baum J., Dogru M., Foulks G.N., Kinoshita S., Laibson P., McCulley J., Murube J., Pflugfelder S.C., Roloando M., and Toda I. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf 2 (2007) 75-92
2. Bachelder R.E., Lipscomb E.A., Lin X., Wendt M.A., Chadborn N.H., Eickholt B.J., and Mercurio A.M. Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res. 63 (2003) 5230-5233
3. Berk R.S., Dong Z., Alousi S., Kosir M.A., Wang Y., and Vlodavsky I. Murine ocular heparanase expression before and during infection with Pseudomonas aeruginosa. Investig. Ophthalmol. Vis. Sci. 45 (2004) 1182-1187
4. Bertolesi G.E., Michaiel G., and McFarlane S. Two heparanase splicing variants with distinct properties are necessary in early Xenopus development. J. Biol. Chem. 283 (2008) 16004-16016
5. Bhaskar P.T., and Hay N. The two TORCs and Akt. Dev. Cell 12 (2007) 487-502
6. Blalock T.D., Spurr-Michaud S.J., Tisdale A.S., Heimer S.R., Gilmore M.S., Ramesh V., and Gipson I.K. Functions of MUC16 in corneal epithelial cells. Investig. Ophthalmol. Vis. Sci. 48 (2007) 4509-4518
7. Blalock T.D., Spurr-Michaud S.J., Tisdale A.S., and Gipson I.K. Release of membrane-associated mucins from ocular surface epithelial. Investig. Ophthalmol. Vis. Sci. 49 (2008) 1864-1871
8. Borzok M.A., Catino D.H., and Nicholson J.D. Mapping the binding site on small ankyrin 1 for obscurin. J. Biol. Chem. 282 (2007) 32384-32396 Kontrogianni-Konstantopoulos, A., Bloch, R.J
9. Chandran J., Ding J., and Cai H. Alsin and the molecular pathways of amyotrophic lateral sclerosis. Mol. Neurobiol. 36 (2007) 224-231
10. Chen Y.G., Siddhanta A., Austin C.D., Hammond S.M., Sung T.C., Frohman M.A., Morris A.J., and Shields D. Phospholipase D stimulates release of nascent secretory vesicles from the trans-Golgi network. J. Cell. Biol. 138 (1997) 495-504
11. Davé V., Childs T., Xu Y., Ikegami M., Besnard V., Maeda Y., Wert S.E., Neilson J.R., Crabtree G.R., and Whitsett J.A. Calcineurin/Nfat signaling is required for perinatal lung maturation and function. J. Clin. Investig. 116 (2006) 2597-2609
12. Donaudy F., Snoeckx R., Pfister M., Zenner H.P., Blin N., Di Stazio M., Ferrara A., Lanzara C., Ficarella R., Declau F., Pusch C.M., Nürnberg P., Melchionda S., Zelante L., Ballana E., Estivill X., Van Camp G., Gasparini P., and Savoia A. Nonmuscle myosin heavy-chain gene MYH14 is expressed in cochlea and mutated in patients affected by autosomal dominant hearing impairment (DFNA4). Am. J. Hum. Genet. 74 (2004) 770-776
13. Fader C.M., Sánchez D., Furlán M., and Colombo M.I. Induction of autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in k562 cells. Traffic 9 (2008) 230-250
14. Garfin D.E. One-dimensional gel electrophoresis. Methods Enzymol. 182 (1990) 425-441
15. Gu S., He J., Ho W.T., Ramineni S., Thal D.M., Natesh R., Tesmer J.J., Hepler J.R., and Heximer S.P. Unique hydrophobic extension of the RGS2 amphipathic helix domain imparts increased plasma membrane binding and function relative to other RGS R4/B subfamily members. J. Biol. Chem. 282 (2007) 33064-33075
16. Green-Church K.B., Sessler R., and Nichols J.J. Proteomic analyses in contact lens-related dry eye. Investig. Ophthalmol. Vis. Sci. 48 (2007) E-Abstract 5405
17. Green-Church K.B., and Nichols J.J. Mass spectrometry-based proteomic analyses of contact lens deposition. Mol. Vis. 14 (2008) 291-297
18. Gurda G.T., Guo L., Lee S.H., Molkentin J.D., and Williams J.A. Cholecystokinin activates pancreatic calcineurin-NFAT signaling in vitro and in vivo. Mol. Biol. Cell. 19 (2008) 198-206
19. Hadano S., Otomo A., Suzuki-Utsunomiya K., Kunita R., Yanagisawa Y., Showguchi- Miyata J., Mizumura H., and Ikeda J.E. ALS2CL, the novel protein highly homologous to the carboxy-terminal half of ALS2, binds to Rab5 and modulates endosome dynamics. FEBS Lett. 575 (2004) 64-70
20. Hawrani A., Howe R.A., Walsh T.R., and Dempsey C.E. Origin of low mammalian cell toxicity in a class of highly active antimicrobial amphipathic helical peptides. J. Biol. Chem. (Apr 23 2008) (Epub ahead of print)
21. van Heel D.A., Franke L., Hunt K.A., Gwilliam R., Zhernakova A., Inouye M., Wapenaar M.C., Barnardo M.C., Bethel G., Holmes G.K., Feighery C., Jewell D., Kelleher D., Kumar P., Travis S., Walters J.R., Sanders D.S., Howdle P., Swift J., Playford R.J., McLaren W.M., Mearin M.L., Mulder C.J., McManus R., McGinnis R., Cardon L.R., Deloukas P., and Wijmenga C. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat. Genet. 39 (2007) 827-829
22. Heimann H., Coupland S.E., Gochman R., Hellmich M., and Foerster M.H. Alterations in expression of mucin, tenascin-c and syndecan-1 in the conjunctiva following retinal surgery and plaque radiotherapy. Graefes Arch. Clin. Exp. Ophthalmol. 239 (2001) 488-495
23. Heit J.J., Apelqvist A.A., Gu X., Winslow M.M., Neilson J.R., Crabtree G.R., and Kim S.K. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature 443 (2006) 345-349
24. Horsley V., Aliprantis A.O., Polak L., Glimcher L.H., and Fuchs E. NFATc1 balances quiescence and proliferation of skin stem cells. Cell 132 (2008) 299-310
25. Huang C.Y., Beliakoff J., Li X., Lee J., Li X., Sharma M., Lim B., and Sun Z. hZimp7, a novel PIAS-like protein, enhances androgen receptor-mediated transcription and interacts with SWI/SNF-like BAF complexes. Mol. Endocrinol. 9 (2005) 2915-2929
26. Hughes W.E., Elgundi Z., Huang P., Frohman M.A., and Biden T.J. Phospholipase D1 regulates secretagogue-stimulated insulin release in pancreatic beta-cells. J. Biol. Chem. 279 (2004) 27534-27541
27. Iakoucheva L.M., Kimzey A.L., Masselon C.D., Smith R.D., Dunker A.K., and Ackerman E.J. Aberrant mobility phenomena of the DNA repair protein XPA. Protein Sci. 10 (2001) 1353-1362
28. Jordan A., and Baum J. Basic tear flow. Does it exist?. Ophthalmology 87 (1980) 920-930
29. Kitagawa, K., Tomosugi, N., Tuchida, H., Sasaki, H., 2007. Automated identification and quantification of tear proteins in Sjögren's syndrome by LC-MS on a hybrid linear ion trap mass spectrometer. In: Fifth International Conference on the Tear Film and Ocular Surface: Basic Science and Clinical Relevance, Taormina, Sicily, Italy.
30. Koo B.S., Lee D.Y., Ha H.S., Kim J.C., and Kim C.W. Comparative analysis of the tear protein expression in blepharitis patients using two-dimensional electrophoresis. J. Proteome Res. 4 (2005) 719-724
31. Laurie G.W., Olsakovsky L.A., Conway B.P., McKown R.L., Kitagawa K., and Nichols J.J. Dry eye and designer ophthalmics. Optom. Vis. Sci. 85 (2008) 643-652
32. Levin M.H., and Verkman A.S. Aquaporin-dependent water permeation at the mouse ocular surface: in vivo microfluorimetric measurements in cornea and conjunctiva. Investig. Ophthalmol. Vis. Sci. 45 (2004) 4423-4432
33. Li Y., Hollingworth P., Moore P., Foy C., Archer N., Powell J., Nowotny P., Holmans P., O'Donovan M., Tacey K., Doil L., van Luchene R., Garcia V., Rowland C., Lau K., Cantanese J., Sninsky J., Hardy J., Thal L., Morris J.C., Goate A., Lovestone S., Owen M., Williams J., and Grupe A. Genetic association of the APP binding protein 2 gene (APBB2) with late onset Alzheimer disease. Hum. Mutat. 25 (2005) 270-277
34. Lonyai A., Kodama S., Burger D., and Faustman D.L. Fetal Hox11 expression patterns predict defective target organs: a novel link between developmental biology and autoimmunity. Immunol. Cell Biol. 86 (2008) 301-309
35. Ma P., Beck S.L., Raab R.W., McKown R.L., Coffman G.L., Utani A., Chirico W.J., Rapraeger A.C., and Laurie G.W. Heparanase deglycanation of syndecan-1 is required for binding of the epithelial-restricted prosecretory mitogen lacritin. J. Cell Biol. 74 (2006) 1097-1106
36. Ma P., Wang N., McKown R.L., Raab R.W., and Laurie G.W. Focus on molecules: lacritin. Exp. Eye Res. 86 (2008) 457-458
37. Majczak G., Lilla S., Garay-Malpartida M., Markovic J., Medrano F.J., de Nucci G., and Belisario J.E. Prediction and biochemical characterization of intrinsic disorder in the structure of proteolysis-inducing factor/dermcidin. Genet. Mol. Res. 6 (2007) 1000-1011
38. Mannan A.U., Krawen P., Sauter S.M., Boehm J., Chronowska A., Paulus W., Neesen J., and Engel W. ZFYVE27 (SPG33), a novel spastin-binding protein, is mutated in hereditary spastic paraplegia. Am. J. Hum. Genet. 79 (2006) 351-357
39. Manoussakis M.N., Boiu S., Korkolopoulou P., Kapsogeorgou E.K., Kavantzas N., Ziakas P., Patsouris E., and Moutsopoulos H.M. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development. Arthritis Rheum. 56 (2007) 3977-3988
40. Merner N.D., Hodgkinson K.A., Haywood A.F., Connors S., French V.M., Drenckhahn J.D., Kupprion C., Ramadanova K., Thierfelder L., McKenna W., Gallagher B., Morris- Larkin L., Bassett A.S., Parfrey P.S., and Young T.L. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am. J. Hum. Genet. 82 (2008) 809-821
41. Mertens F., Fletcher C.D., Antonescu C.R., Coindre J.M., Colecchia M., Domanski H.A., Downs-Kelly E., Fisher C., Goldblum J.R., Guillou L., Reid R., Rosai J., Sciot R., Mandahl N., and Panagopoulos I. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab. Investig. 85 (2005) 408-415
42. Murakami T., Fujihara T., Nakamura M., and Nakata K. P2Y(2) receptor elicits PAS- positive glycoprotein secretion from rabbit conjunctival goblet cells in vivo. J. Ocul. Pharmacol. Ther. 9 (2003) 345-352
43. Nakajima T., Walkup R.D., Tochigi A., Shearer T.R., and Azuma M. Establishment of an appropriate animal model for lacritin studies: cloning and characterization of lacritin in monkey eyes. Exp. Eye Res. 85 (2007) 651-658
44. Nasser N.J. Heparanase involvement in physiology and disease. Cell Mol. Life Sci. 65 (2008) 1706-1715
45. Ozyildirim A.M., Wistow G.J., Gao J., Wang J., Dickinson D.P., Frierson Jr. H.F., and Laurie G.W. The lacrimal gland transcriptome is an unusually rich source of rare and poorly characterized gene transcripts. Investig. Ophthalmol. Vis. Sci. 46 (2005) 1572-1580
46. Patel V.N., Knox S.M., Likar K.M., Lathrop C.A., Hossain R., Eftekhari S., Whitelock J.M., Elkin M., Vlodavsky I., and Hoffman M.P. Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis. Development 134 (2007) 4177-4186
47. Pioszak A.A., and Xu H.E. Molecular recognition of parathyroid hormone by its G protein-coupled receptor. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 5034-5039
48. Porter D., Weremowicz S., Chin K., Seth P., Keshaviah A., Lahti-Domenici J., Bae Y.K., Monitto C.L., Merlos-Suarez A., Chan J., Hulette C.M., Richardson A., Morton C.C., Marks J., Duyao M., Hruban R., Gabrielson E., Gelman R., and Polyak K. A neural survival factor is a candidate oncogene in breast cancer. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 10931-10936
49. Proikas-Cezanne T., Ruckerbauer S., Stierhof Y.D., Berg C., and Nordheim A. Human WIPI-1 puncta-formation: a novel assay to assess mammalian autophagy. FEBS Lett. 581 (2007) 3396-3404
50. Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T., and Loo J.A. Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry. J. Proteome Res. 5 (2006) 1493-1503
51. Rolando M., and Zierhut M. The ocular surface and tear film and their dysfunction in dry eye disease. Surv. Ophthalmol. 45 (2001) S203-210
52. Runge S., Thøgersen H., Madsen K., Lau J., and Rudolph R. Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. J. Biol. Chem. 283 (2008) 11340-11347
53. Sanghi S., Kumar R., Lumsden A., Dickinson D., Klepeis V., Trinkaus-Randall V., Frierson Jr. H.F., and Laurie G.W. cDNA and genomic cloning of lacritin, a novel secretion enhancing factor from the human lacrimal gland. J. Mol. Biol. 310 (2001) 127-139
54. Samudre, S.S., Schneider, J.L., Loose-Thurman, P., Sheppard, J.D., Laurie, G.W., McKown, R.L., Williams, P.B. Lacritin, a novel tear glycoprotein, stimulates tear production in rabbits without ocular toxicity. submitted for publication.
55. Schaumberg D.A., Buring J.E., Sullivan D.A., and Dana M.R. Hormone replacement therapy and dry eye syndrome. JAMA 286 (2001) 2114-2119
56. Shafat I., Vlodavsky I., and Ilan N. Characterization of mechanisms involved in secretion of active heparanase. J. Biol. Chem. 281 (2006) 23804-23811
57. Shirane M., and Nakayama K.I. Protrudin induces neurite formation by directional membrane trafficking. Science 314 (2006) 818-821
58. Smoot M.E., Guerlain S.A., and Pearson W.R. Visualization of near-optimal sequence alignments. Bioinformatics 20 (2004) 953-958
59. de Souza G.A., Godoy L.M., and Mann M. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol. 7 (2006) R72
60. Stern M.E., Gao J., Siemasko K.F., Beuerman R.W., and Pflugfelder S.C. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp. Eye Res. 78 (2004) 409-416
61. Stevanin G., Santorelli F.M., Azzedine H., Coutinho P., Chomilier J., Denora P.S., Martin E., Ouvrard-Hernandez A.M., Tessa A., Bouslam N., Lossos A., Charles P., Loureiro J.L., Elleuch N., Confavreux C., Cruz V.T., Ruberg M., Leguern E., Grid D., Tazir M., Fontaine B., Filla A., Bertini E., Durr A., and Brice A. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat. Genet. 39 (2007) 366-372
62. Sullivan D.A. Tearful relationships? Sex, hormones, the lacrimal gland, and aqueous- deficient dry eye. Ocul. Surf. 2 (2004) 92-123
63. Sumiyoshi M., Ricciuto J., Tisdale A., Gipson I.K., Mantelli F., and Argüeso P. Antiadhesive character of mucin O-glycans at the apical surface of corneal epithelial cells. Investig. Ophthalmol. Vis. Sci. 49 (2008) 197-203
64. Suzuki-Utsunomiya K., Hadano S., Otomo A., Kunita R., Mizumura H., Osuga H., and Ikeda J.E. ALS2CL, a novel ALS2-interactor, modulates ALS2-mediated endosome dynamics. Biochem. Biophys. Res. Commun. 354 (2007) 491-497
65. Takegahara N., Takamatsu H., Toyofuku T., Tsujimura T., Okuno T., Yukawa K., Mizui M., Yamamoto M., Prasad D.V., Suzuki K., Ishii M., Terai K., Moriya M., Nakatsuji Y., Sakoda S., Sato S., Akira S., Takeda K., Inui M., Takai T., Ikawa M., Okabe M., Kumanogoh A., and Kikutani H. Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nat. Cell Biol. 8 (2006) 615-622
66. Tauber J., Davitt W.F., Bokosky J.E., Nichols K.K., Yerxa B.R., Schaberg A.E., LaVange L.M., Mills-Wilson M.C., and Kellerman D.J. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye. Cornea 23 (2004) 784-792
67. Tomosugi N., Kitagawa K., Takahashi N., Sugai S., and Ishikawa I. Diagnostic potential of tear proteomic patterns in Sjögren's syndrome. J. Proteome Res. 4 (2005) 820-825
68. Tsai P.S., Evans J.E., Green K.M., Sullivan R.M., Schaumberg D.A., Richards S.M., Dana M.R., and Sullivan D.A. Proteomic analysis of human meibomian gland secretions. Br. J. Ophthalmol. 90 (2006) 372-377
69. Ubels J.L., Wertz J.T., Ingersoll K.E., Jackson II R.S., and Aupperlee M.D. Down-regulation of androgen receptor expression and inhibition of lacrimal gland cell proliferation by retinoic acid. Exp. Eye Res. 75 (2002) 561-571
70. Van Goethem G., Martin J.J., and Van Broeckhoven C. Progressive external ophthalmoplegia and multiple mitochondrial DNA deletions. Acta Neurol. Belg 102 (2002) 39-42
71. Wang J., Wang N., Xie J., Walton S.C., McKown R.L., Raab R.W., Ma P., Beck S.L., Coffman G.L., Hussaini I.M., and Laurie G.W. Restricted epithelial proliferation by lacritin via PKCalpha-dependent NFAT and mTOR pathways. J. Cell Biol. 174 (2006) 689-700
72. Yang T., Zeng H., Zhang J., Okamoto C.T., Warren D.W., Wood R.L., Bachmann M., and Mircheff A.K. Stimulation with carbachol alters endomembrane distribution and plasma membrane expression of intracellular proteins in lacrimal acinar cells. Exp. Eye Res. 69 (1999) 651-661
73. Zcharia E., Philp D., Edovitsky E., Aingorn H., Metzger S., Kleinman H.K., Vlodavsky I., and Elkin M. Heparanase regulates murine hair growth. Am. J. Pathol. 166 (2005) 999-1008
74. Zhernakova A., Alizadeh B.Z., Bevova M., van Leeuwen M.A., Coenen M.J., Franke B., Franke L., Posthumus M.D., van Heel D.A., van der Steege G., Radstake T.R., Barrera P., Roep B.O., Koeleman B.P., and Wijmenga C. Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases. Am. J. Hum. Genet. 81 (2007) 1284-1288
75. Zhou L., Beuerman R.W., Foo Y., Liu S., Ang L.P., and Tan D.T. Characterisation of human tear proteins using high-resolution mass spectrometry. Ann. Acad. Med. Singap. 35 (2006) 400-407